Reconsidering the Diagnosis: Abnormal Sweat Chloride Tests in Non-CF Bronchiectasis

Overview

Journal Pediatr Pulmonol

Date 2025 Jan 8

PMID 39778078

Authors

Reyna L Huang

Matthew T Snyder

Nuzhat Fahmida

Dana P Albon

Affiliations

Soon will be listed here.

Abstract

Introduction: While the diagnosis of cystic fibrosis (CF) is often straightforward and reliant on correlation between genetic testing and clinical signs and symptoms, there is a subset where the distinction is not nearly as clearcut. This has previously been reported in patients identified through newborn screening but not meeting full CF diagnostic criteria, earning the label of CF Screen Positive, Inconclusive Diagnosis (CFSPID) instead. A homologous diagnostic category in adults is named CF Transmembrane Conductance Regulator-Related Disorder (CFTR-RD).

Methods: Through a retrospective chart review, this study reports on a relatively large adult cohort (n = 23) that presented to pulmonology clinic at a single center with intermediate or positive sweat chloride tests but non-diagnostic full CFTR gene analysis.

Results: Median sweat chloride result was 48 mmol/L, and a majority of the cohort had chronic lung disease with atypical pathogens on sputum culture, including Pseudomonas aeruginosa, non-tuberculous Mycobacteria, Acinetobacter species, amongst others.

Conclusions: This clinical picture suggests CFTR dysfunction or similar mechanism in the absence of an identified genetic cause. Alternate chloride channels and their respective genes or candidates of genetic modifiers to the CF-phenotype could be targets of further research in this cohort or similar patients. Such genetic modifiers include loci that have been implicated in inflammation, the CFTR interactome, and/or co-/post-translational modification of CFTR.

References

Guglani L, Stabel D, Weiner D . False-Positive and False-Negative Sweat Tests: Systematic Review of the Evidence. Pediatr Allergy Immunol Pulmonol. 2022; 28(4):198-211. DOI: 10.1089/ped.2015.0552. View

Aksamit T, ODonnell A, Barker A, Olivier K, Winthrop K, Daniels M . Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry. Chest. 2016; 151(5):982-992. PMC: 6026266. DOI: 10.1016/j.chest.2016.10.055. View

Gallati S . Disease-modifying genes and monogenic disorders: experience in cystic fibrosis. Appl Clin Genet. 2014; 7:133-46. PMC: 4104546. DOI: 10.2147/TACG.S18675. View

Stanke F, Becker T, Cuppens H, Kumar V, Cassiman J, Jansen S . The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis. Hum Genet. 2006; 119(3):331-43. DOI: 10.1007/s00439-006-0140-2. View

Barben J, Castellani C, Munck A, Davies J, de Winter-de Groot K, Gartner S . Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID). J Cyst Fibros. 2020; 20(5):810-819. DOI: 10.1016/j.jcf.2020.11.006. View

De Wachter E, De Boeck K, Sermet-Gaudelus I, Simmonds N, Munck A, Naehrlich L . ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals. J Cyst Fibros. 2024; 23(3):388-397. DOI: 10.1016/j.jcf.2024.01.012. View

Butnariu L, Tarca E, Cojocaru E, Rusu C, Moisa S, Leon Constantin M . Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine. J Clin Med. 2021; 10(24). PMC: 8707808. DOI: 10.3390/jcm10245821. View

Wright F, Strug L, Doshi V, Commander C, Blackman S, Sun L . Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet. 2011; 43(6):539-46. PMC: 3296486. DOI: 10.1038/ng.838. View

Corvol H, Blackman S, Boelle P, Gallins P, Pace R, Stonebraker J . Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun. 2015; 6:8382. PMC: 4589222. DOI: 10.1038/ncomms9382. View

10.

Rodman D, Polis J, Heltshe S, Sontag M, Chacon C, Rodman R . Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med. 2004; 171(6):621-6. DOI: 10.1164/rccm.200403-404OC. View

11.

Dorfman R, Sandford A, Taylor C, Huang B, Frangolias D, Wang Y . Complex two-gene modulation of lung disease severity in children with cystic fibrosis. J Clin Invest. 2008; 118(3):1040-9. PMC: 2248329. DOI: 10.1172/JCI33754. View

12.

Bremer L, Blackman S, Vanscoy L, McDougal K, Bowers A, Naughton K . Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. Hum Mol Genet. 2008; 17(14):2228-37. PMC: 2902288. DOI: 10.1093/hmg/ddn123. View

13.

Barry P, Simmonds N . Diagnosing Cystic Fibrosis in Adults. Semin Respir Crit Care Med. 2023; 44(2):242-251. DOI: 10.1055/s-0042-1759881. View

14.

Dumas M, Xia S, Bear C, Ratjen F . Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis. EBioMedicine. 2021; 73:103660. PMC: 8577330. DOI: 10.1016/j.ebiom.2021.103660. View

15.

Chalmers J, Polverino E, Crichton M, Ringshausen F, Soyza A, Vendrell M . Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). Lancet Respir Med. 2023; 11(7):637-649. DOI: 10.1016/S2213-2600(23)00093-0. View

16.

McClure M, Barnes S, Brodsky J, Sorscher E . Trafficking and function of the cystic fibrosis transmembrane conductance regulator: a complex network of posttranslational modifications. Am J Physiol Lung Cell Mol Physiol. 2016; 311(4):L719-L733. PMC: 5142128. DOI: 10.1152/ajplung.00431.2015. View

17.

Mishra A, Greaves R, Smith K, Carlin J, Wootton A, Stirling R . Diagnosis of cystic fibrosis by sweat testing: age-specific reference intervals. J Pediatr. 2008; 153(6):758-63. DOI: 10.1016/j.jpeds.2008.04.067. View

18.

Ginsburg D, Wee C, Reyes M, Brewington J, Salinas D . When CFSPID becomes CF. J Cyst Fibros. 2021; 21(1):e23-e27. DOI: 10.1016/j.jcf.2021.06.012. View

19.

Dorfman R, Taylor C, Lin F, Sun L, Sandford A, Pare P . Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis. Pediatr Pulmonol. 2010; 46(4):385-92. DOI: 10.1002/ppul.21372. View